Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Shrinking team NBB
FTE fell two years in a row, from 4.8 to 3.5.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
The Akkermansia Company from Mont-Saint-Guibert, company number BE0664529083, closed financial year 2024 with a result of € -3.6 million after tax. For that financial year The Akkermansia Company recorded a gross margin of € -1.5 million and equity of € 6.7 million. Compared with financial year 2023, the result moved from € -5 million to € -3.6 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2025.
€ 6.7 million
▼ 36% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3.6 million
▲ 27 % less loss than in 2023
Profit after tax over the fiscal year.
€ 6.6 million
▲ 61% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -22.2 million.
People and assets in 2024
3.5
▼ 0.6 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 269,867
▼ 34% vs 2023
€ 77,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,614
▼ 25% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 8.1 million
▲ € 8.1 million vs 2023
€ 134,077 is repaid this year. At this pace the long-term loan is gone in ≈ 61 years.
€ 2.7 million
▲ 45% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 51,367
▼ 53% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -2,156,853 | € -3,253,066 | € -3,959,687 | € -1,485,173 | ▲ € 2.5 million |
| Profit after taxes | € -3,348,585 | € -4,234,402 | € -5,024,764 | € -3,645,948 | ▲ € 1.4 million |
| Equity | € 11,493,259 | € 6,635,790 | € 10,412,446 | € 6,655,735 | ▼ 36% |
| Total debts | € 1,359,741 | € 2,636,534 | € 3,016,797 | € 11,981,115 | ▲ 297% |
| Cash | € 6,433,044 | € 478,228 | € 4,102,140 | € 6,608,881 | ▲ 61% |
| Retained profit | € -9,308,235 | € -13,542,637 | € -18,567,400 | € -22,213,347 | ▼ € 3.6 million |
| Bank debt | € 0 | € 0 | € 56,544 | € 8,134,077 | ▲ € 8.1 million |
| Balance sheet total | € 12,853,000 | € 9,272,324 | € 13,429,243 | € 18,636,850 | ▲ 39% |
| Employees (FTE) | 6 | 4.8 | 4.1 | 3.5 | ▼ 0.6 |
Key figures of The Akkermansia Company, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to The Akkermansia Company?
What happened at The Akkermansia Company in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 3.6 million. Source: NBB ↗
- Seventure Partners stepped down as director. NBB
- Alogis AB stepped down as director. NBB
- Innovation Industries Fund Coöperatief UA stepped down as director. NBB
- Vives Partners stepped down as director. NBB
- Alopekos Holding BV stepped down as director. NBB
- Sparaxis SA stepped down as director. NBB
- John Agwunobi stepped down as director. NBB
In short
From € 3.3 million loss in 2021 to € 3.6 million loss in 2024.
Paid € 45,583 in corporate taxes since 2021.
A new publication or filing at The Akkermansia Company? We notify you, reason included.
Follow The Akkermansia CompanyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Wallonie Entreprendre, VIVES II - Louvain Technology Fund, SOPARTEC, SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
The Akkermansia CompanyThe shares are held by Wallonie Entreprendre (13.3%), VIVES II - Louvain Technology Fund (12%), SOPARTEC (5.7%) and SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (2%).
Directors
According to the 2024 annual accounts
Director · represented by Philippe Durieux
Also active at: n-Side, NOVADIP BIOSCIENCES, TESSARES, AXINESIS, Sunrise, ViroVet, VOCSens, Vives Inter-University Fund +7 more
since 2023 · until 2024
Seventure Partners
Director · represented by Nora Frey
since 2023 · until 2025
Chairman of the board · represented by Erici Ola
since 2023 · until 2025
Innovation Industries Fund Coöperatief UA
Director · represented by Caaj Grebe
since 2023 · until 2025
Director · represented by Philippe Durieux
Also active at: NOVADIP BIOSCIENCES, TESSARES, AXINESIS, Sunrise, ViroVet, VOCSens, Vives Inter-University Fund, NeGIO Therapeutics +4 more
since 2024 · until 2025
Alopekos Holding BV
Director · represented by Willem de Vos
since 2023 · until 2025
Director · represented by Sophie Sauvage
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International, Ateliers Pierre Cerfontaine, Floridienne, Fonderies J. Marichal Ketin et Cie, JUNGLING, MEBF +223 more
since 2023 · until 2025
John Agwunobi
Director
since 2023 · until 2025
Nothern Lights Southern Cross Belgium SRL
Managing director · represented by Michael Oredsson
since 2023 · until 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Granbonpré 11
1435 Mont-Saint-Guibert
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →DE SMET AGRO
€ 8.7 million revenue · 2025
DE SMET S.A. - ENGINEERS & CONTRACTORS same network
€ 31.8 million revenue · 2025
CEDRIC CLAERHOUDT
€ 937,969 gross margin · 2024
Tools4Patient same network
€ -431,027 gross margin · 2025
NOVADIP BIOSCIENCES same network
€ 1.6 million gross margin · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0664.529.083
- VAT number
- BE 0664.529.083
- Registered office
- Rue Granbonpré 11, 1435 Mont-Saint-Guibert
- Names & denominations
- The Akkermansia Company
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 October 2016
- Peppol
- Active · Active since 2 Feb 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied